Calpain-mediated tau fragmentation is altered in Alzheimer’s disease progression
Open Access
- 13 November 2018
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 16725
Abstract
The aggregation of intracellular tau protein is a major hallmark of Alzheimer’s disease (AD). The extent and the stereotypical spread of tau pathology in the AD brain are correlated with cognitive decline during disease progression. Here we present an in-depth analysis of endogenous tau fragmentation in a well-characterized cohort of AD and age-matched control subjects. Using protein mass spectrometry and Edman degradation to interrogate endogenous tau fragments in the human brain, we identified two novel proteolytic sites, G323 and G326, as major tau cleavage events in both normal and AD cortex. These sites are located within the sequence recently identified as the structural core of tau protofilaments, suggesting an inhibitory mechanism of fibril formation. In contrast, a different set of novel cleavages showed a distinct increase in late stage AD. These disease-associated sites are located outside of the protofilament core sequence. We demonstrate that calpain 1 specifically cleaves at both the normal and diseased sites in vitro, and the site selection is conformation-dependent. Monomeric tau is predominantly cleaved at G323/G326 (normal sites), whereas oligomerization increases cleavages at the late-AD-associated sites. The fragmentation patterns specific to disease and healthy states suggest novel regulatory mechanisms of tau aggregation in the human brain.Keywords
This publication has 60 references indexed in Scilit:
- Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer’s DiseasePLOS ONE, 2013
- Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model TauopathyPLOS ONE, 2013
- Human High Temperature Requirement Serine Protease A1 (HTRA1) Degrades Tau Protein AggregatesJournal of Biological Chemistry, 2012
- Animal models reveal role for tau phosphorylation in human diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- Concurrent calpain and caspase-3 mediated proteolysis of αII-spectrin and tau in rat brain after methamphetamine exposure: A similar profile to traumatic brain injuryLife Sciences, 2005
- The Generation of a 17 kDa Neurotoxic Fragment: An Alternative Mechanism by which Tau Mediates β-Amyloid-Induced NeurodegenerationThe Journal of Neuroscience, 2005
- FTDP‐17 tau mutations decrease the susceptibility of tau to calpain I digestionFEBS Letters, 1999
- Calpain‐Induced Proteolysis of Normal Human Tau and Tau Associated with Paired Helical FilamentsEuropean Journal of Biochemistry, 1995
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Proteolysis of tau by calpainBiochemical and Biophysical Research Communications, 1989